963 related articles for article (PubMed ID: 32161398)
41. Regorafenib in combination with immune checkpoint inhibitors for mismatch repair proficient (pMMR)/microsatellite stable (MSS) colorectal cancer.
Akin Telli T; Bregni G; Vanhooren M; Saude Conde R; Hendlisz A; Sclafani F
Cancer Treat Rev; 2022 Nov; 110():102460. PubMed ID: 36058142
[TBL] [Abstract][Full Text] [Related]
42. Radiotherapy and immunotherapy: a beneficial liaison?
Weichselbaum RR; Liang H; Deng L; Fu YX
Nat Rev Clin Oncol; 2017 Jun; 14(6):365-379. PubMed ID: 28094262
[TBL] [Abstract][Full Text] [Related]
43. Salmonella Induces the cGAS-STING-Dependent Type I Interferon Response in Murine Macrophages by Triggering mtDNA Release.
Xu L; Li M; Yang Y; Zhang C; Xie Z; Tang J; Shi Z; Chen S; Li G; Gu Y; Wang X; Zhang F; Wang Y; Shen X
mBio; 2022 Jun; 13(3):e0363221. PubMed ID: 35604097
[TBL] [Abstract][Full Text] [Related]
44. Comprehensive analysis of multiple parameters associated with tumor immune microenvironment in
Li Z; Lin J; Zhang L; Li J; Zhang Y; Zhao C; Wang H
Future Oncol; 2020 Oct; 16(29):2295-2306. PubMed ID: 32639175
[No Abstract] [Full Text] [Related]
45. H3.3-G34 mutations impair DNA repair and promote cGAS/STING-mediated immune responses in pediatric high-grade glioma models.
Haase S; Banerjee K; Mujeeb AA; Hartlage CS; Núñez FM; Núñez FJ; Alghamri MS; Kadiyala P; Carney S; Barissi MN; Taher AW; Brumley EK; Thompson S; Dreyer JT; Alindogan CT; Garcia-Fabiani MB; Comba A; Venneti S; Ravikumar V; Koschmann C; Carcaboso ÁM; Vinci M; Rao A; Yu JS; Lowenstein PR; Castro MG
J Clin Invest; 2022 Nov; 132(22):. PubMed ID: 36125896
[TBL] [Abstract][Full Text] [Related]
46. Reprogramming the tumour microenvironment by radiotherapy: implications for radiotherapy and immunotherapy combinations.
Colton M; Cheadle EJ; Honeychurch J; Illidge TM
Radiat Oncol; 2020 Nov; 15(1):254. PubMed ID: 33148287
[TBL] [Abstract][Full Text] [Related]
47. cGAS-STING signaling in cancer immunity and immunotherapy.
Du H; Xu T; Cui M
Biomed Pharmacother; 2021 Jan; 133():110972. PubMed ID: 33254021
[TBL] [Abstract][Full Text] [Related]
48. Combining radiation and the ATR inhibitor berzosertib activates STING signaling and enhances immunotherapy via inhibiting SHP1 function in colorectal cancer.
Liu C; Wang X; Qin W; Tu J; Li C; Zhao W; Ma L; Liu B; Qiu H; Yuan X
Cancer Commun (Lond); 2023 Apr; 43(4):435-454. PubMed ID: 36855844
[TBL] [Abstract][Full Text] [Related]
49. The cGAS/STING Pathway: A Novel Target for Cancer Therapy.
Gan Y; Li X; Han S; Liang Q; Ma X; Rong P; Wang W; Li W
Front Immunol; 2021; 12():795401. PubMed ID: 35046953
[TBL] [Abstract][Full Text] [Related]
50. The complementarity of DDR, nucleic acids and anti-tumour immunity.
Kornepati AVR; Rogers CM; Sung P; Curiel TJ
Nature; 2023 Jul; 619(7970):475-486. PubMed ID: 37468584
[TBL] [Abstract][Full Text] [Related]
51. Nuclear cGAS suppresses DNA repair and promotes tumorigenesis.
Liu H; Zhang H; Wu X; Ma D; Wu J; Wang L; Jiang Y; Fei Y; Zhu C; Tan R; Jungblut P; Pei G; Dorhoi A; Yan Q; Zhang F; Zheng R; Liu S; Liang H; Liu Z; Yang H; Chen J; Wang P; Tang T; Peng W; Hu Z; Xu Z; Huang X; Wang J; Li H; Zhou Y; Liu F; Yan D; Kaufmann SHE; Chen C; Mao Z; Ge B
Nature; 2018 Nov; 563(7729):131-136. PubMed ID: 30356214
[TBL] [Abstract][Full Text] [Related]
52. A narrative review of combined stereotactic ablative radiotherapy and immunotherapy in metastatic non-small cell lung cancer.
Akanda ZZ; Neeson PJ; John T; Barnett S; Hanna GG; Miller A; Jennens R; Siva S
Transl Lung Cancer Res; 2021 Jun; 10(6):2766-2778. PubMed ID: 34295676
[TBL] [Abstract][Full Text] [Related]
53. The cGAS-STING pathway and cancer.
Samson N; Ablasser A
Nat Cancer; 2022 Dec; 3(12):1452-1463. PubMed ID: 36510011
[TBL] [Abstract][Full Text] [Related]
54. Post-Translational Modifications of cGAS-STING: A Critical Switch for Immune Regulation.
Yu Y; Liu J; Liu C; Liu R; Liu L; Yu Z; Zhuang J; Sun C
Cells; 2022 Sep; 11(19):. PubMed ID: 36231006
[TBL] [Abstract][Full Text] [Related]
55. Zinc cyclic di-AMP nanoparticles target and suppress tumours via endothelial STING activation and tumour-associated macrophage reinvigoration.
Yang K; Han W; Jiang X; Piffko A; Bugno J; Han C; Li S; Liang H; Xu Z; Zheng W; Wang L; Wang J; Huang X; Ting JPY; Fu YX; Lin W; Weichselbaum RR
Nat Nanotechnol; 2022 Dec; 17(12):1322-1331. PubMed ID: 36302963
[TBL] [Abstract][Full Text] [Related]
56. The cGAS/STING/TBK1/IRF3 innate immunity pathway maintains chromosomal stability through regulation of p21 levels.
Basit A; Cho MG; Kim EY; Kwon D; Kang SJ; Lee JH
Exp Mol Med; 2020 Apr; 52(4):643-657. PubMed ID: 32284536
[TBL] [Abstract][Full Text] [Related]
57. DNA Damage and Cancer Immunotherapy: A STING in the Tale.
Reisländer T; Groelly FJ; Tarsounas M
Mol Cell; 2020 Oct; 80(1):21-28. PubMed ID: 32810436
[TBL] [Abstract][Full Text] [Related]
58. A new dawn for eosinophils in the tumour microenvironment.
Grisaru-Tal S; Itan M; Klion AD; Munitz A
Nat Rev Cancer; 2020 Oct; 20(10):594-607. PubMed ID: 32678342
[TBL] [Abstract][Full Text] [Related]
59. Interaction of EGFR with the tumour microenvironment: implications for radiation treatment.
Nijkamp MM; Span PN; Bussink J; Kaanders JH
Radiother Oncol; 2013 Jul; 108(1):17-23. PubMed ID: 23746695
[TBL] [Abstract][Full Text] [Related]
60. A General Biomineralization Strategy to Synthesize Autologous Cancer Vaccines with cGAS-STING Activating Capacity for Postsurgical Immunotherapy.
Li Q; Dong Z; Cao Z; Lei H; Wang C; Hao Y; Feng L; Liu Z
ACS Nano; 2023 Jun; 17(11):10496-10510. PubMed ID: 37184402
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]